Lv2
104 积分 2025-11-05 加入
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
10小时前
待确认
Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma
2个月前
已完结
Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma
2个月前
已完结
GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma
2个月前
已完结
Osimertinib activates a TGF-β2–dependent secretory program that drives lung adenocarcinoma progression
2个月前
已完结
GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma
2个月前
已完结
CRISPR/Cas9 library screening uncovered CCT2 as a critical driver of acquired resistance to EGFR-targeted therapy by stabilizing TMX1 in non-small cell lung cancer
4个月前
已完结
Hypoxia inducible factor-1α drives cancer resistance to cuproptosis
5个月前
已完结
Hypoxia inducible factor-1α drives cancer resistance to cuproptosis
5个月前
已完结
A ROS-mediated oxidation-O-GlcNAcylation cascade governs ferroptosis
5个月前
已完结
皖公网安备34019202002308
